Association of HLA-DRw9 with myasthenia gravis in Chinese

H C Chiu1, R P Hsieh, K H Hsieh

  • 1Department of Neurology, College of Medicine, National Taiwan University, Taipei, Republic of China.

Journal of Immunogenetics
|August 1, 1987
PubMed

Insights

This study found specific human leukocyte antigen (HLA) types, particularly HLA-DRw9 and HLA-Bw46, are significantly more common in Chinese myasthenia gravis (MG) patients, suggesting a genetic link to the disease.

Area of Science:

  • Immunogenetics
  • Human Leukocyte Antigen (HLA) complex
  • Autoimmune Diseases

Background:

  • Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
  • Genetic factors, particularly HLA phenotypes, are implicated in MG susceptibility.
  • Understanding HLA associations can provide insights into MG pathogenesis.

Purpose of the Study:

  • To investigate the association between specific HLA phenotypes and myasthenia gravis (MG) in a Chinese population.
  • To identify potential genetic markers for MG risk and subtypes.

Main Methods:

  • Human leukocyte antigen (HLA) typing was performed on 59 Chinese MG patients and 79 healthy controls.
  • Peripheral blood mononuclear cells and B-enriched lymphocytes were used for HLA-A, B, C, and DR typing.
  • Statistical analysis, including chi-squared tests, was used to compare allele frequencies.

Main Results:

  • Significant increases in HLA-Bw46 and HLA-DRw9 frequencies were observed in MG patients compared to controls.
  • HLA-DR3 frequency was significantly decreased in MG patients.
  • The association with HLA-DRw9 appeared primary, with HLA-Bw46 being secondary.
  • The HLA-A2-Bw46-DRw9 haplotype was significantly increased in MG patients, particularly in younger onset subgroups.

Conclusions:

  • Specific HLA phenotypes, notably HLA-DRw9 and HLA-Bw46, are strongly associated with myasthenia gravis in the Chinese population.
  • These findings suggest a significant genetic predisposition to MG linked to these HLA alleles.
  • The identified HLA combinations may serve as potential biomarkers for MG risk stratification.

Related Concept Videos

Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...